BioSpace News Archive

Employer Resources

Women in Life Sciences: Tipping the Balance

We interviewed Dr. Jo Viney, Co-Founder, President, and CSO of Pandion Therapeutics. Dr. Viney discussed her experience working within large organizations and ultimately starting her own company.

December 11, 2019
·
6 min read
·
Porschia Parker
Business

Creoptix Appoints Line Stigen Raquet as Chief Executive Officer

Creoptix AG announced the appointment of Line Stigen Raquet as Chief Executive Officer with effect from beginning of January 2020.

December 11, 2019
·
2 min read
Owlstone Medical to Join EU-Funded EPHOR Consortium to Advance Occupational Health Science in Order to Reduce Disease Burden from Workplace Exposure

Owlstone Medical will receive funding to deploy Breath Biopsy® as part of EPHOR

December 11, 2019
·
6 min read
Business

Rho’s Dr. Meagan E. Spychala Promoted to Assistant VP of Patient Engagement and Program Strategy

Dr. Spychala Brings Patient-Centricity and Rare Disease Clinical Research Expertise to New Role

December 11, 2019
·
2 min read
Drug Development

BioSpace Global Roundup, Dec. 12

Companies from across the globe provide updates to their business and pipelines.

December 11, 2019
·
6 min read
·
Alex Keown
PHARMASEAL Scoops its First Industry Award as Best Start-Up of the Year At Medilink East Midlands Business Awards 2019

PHARMASEAL, a new provider of clinical trial management and governance solutions to enter the market, announces that is has won Start-Up of the Year in the 2019 Medilink East Midlands Business Awards.

December 11, 2019
·
3 min read
The Quinze-Vingts Hospital and GenSight Biologics announce a first Temporary Authorization for Use (ATU) for LUMEVOQTM (GS010) in France

The National Eye Hospital of the Quinze- Vingts in Paris and GenSight Biologics announced that the French Competent Authority, the National Drug Safety Agency, granted a named patient Temporary Authorization for Use for LUMEVOQTM to the CHNO of the Quinze-Vingts.

December 11, 2019
·
6 min read
Deals

La Jolla Institute for Immunology acquires Berkeley Lights Beacon® platform

The Beacon optofluidic technology will be used to speed the identification of lifesaving treatments for deadly viruses including Ebola, Lassa and others.

December 11, 2019
·
3 min read
Business

Amgen Lines up Space in Bay Area’s Gateway of the Pacific Development

Amgen announced the 240,000-square-foot facility, which is still under construction, will house the company’s Bay Area employees focused on cardiometabolic, inflammation and oncology, research.

December 11, 2019
·
2 min read
·
Alex Keown
Business

Aligos CEO Discusses Progress on Developing HBV Treatments

Aligos Chief Executive Officer Lawrence Blatt told BioSpace that the different assets in development address different components of the infection.

December 11, 2019
·
4 min read
·
Alex Keown